Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02241928
Other study ID # NGBSI-14
Secondary ID
Status Withdrawn
Phase Phase 1
First received
Last updated
Start date January 2009
Est. completion date May 2019

Study information

Verified date October 2018
Source Neurogen Brain and Spine Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study was to analyze the effect of autologous bone marrow mononuclear cells in muscular dystrophy.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date May 2019
Est. primary completion date December 2018
Accepts healthy volunteers No
Gender All
Age group 6 Months to 60 Years
Eligibility Inclusion Criteria:

- age group of 6 months and above

- muscular dystrophy diagnosed on the basis of clinical presentation

Exclusion Criteria:

- presence of respiratory distress

- presence of acute infections such as Human Immunodeficient Virus/Hepatitis B Virus/Hepatitis C Virus

- malignancies

- acute medical conditions such as respiratory infection, fever, hemoglobin less than 8, bleeding tendency, bone marrow disorder, left ventricular ejection fraction < 30%

- pregnancy or breastfeeding

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Stem Cell
Intrathecal Autologous bone marrow mononuclear cell transplantation

Locations

Country Name City State
India Neurogen brain and spine institute Navi Mumbai Maharashtra

Sponsors (1)

Lead Sponsor Collaborator
Neurogen Brain and Spine Institute

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Manual Muscle Testing 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT01834040 - Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy Phase 1/Phase 2
Recruiting NCT01834066 - Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy. Phase 1/Phase 2
Recruiting NCT00082108 - Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
Recruiting NCT00138931 - Genetics of Cardiovascular and Neuromuscular Disease
Completed NCT00622453 - Arrhythmias in Myotonic Muscular Dystrophy N/A
Active, not recruiting NCT04038138 - Clinical Trial Readiness Network FSHD France: Prospective 24 Months MRI Study N/A
Completed NCT01451281 - Studying Skeletal Muscle, Heart, and Diaphragm Imaging in Boys With Duchenne Muscular Dystrophy
Not yet recruiting NCT05470478 - iBCI Optimization for Veterans With Paralysis N/A
Completed NCT04154098 - Evaluation of a Textile Scapula Orthosis N/A
Terminated NCT02653833 - The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy Early Phase 1
Not yet recruiting NCT06363526 - Effectiveness of 5-week Digital Respiratory Practice in a Group of Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy. N/A
Completed NCT01990976 - Study of Morphology and Functional Magnetic Resonance Imaging (MRI) Muscle Patients With Muscular Dystrophy Type FSHD Benefiting a Physical Training Introduced. N/A
Completed NCT01393444 - ECoG Direct Brain Interface for Individuals With Upper Limb Paralysis N/A
Recruiting NCT00912041 - BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia N/A
Completed NCT00866112 - A Randomized Exercise Trial for Wheelchair Users N/A
Completed NCT01882400 - Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy Phase 4
Recruiting NCT05726591 - Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders N/A
Completed NCT02815878 - Enhance Wellness for Individuals With Long-Term Physical Disabilities N/A
Completed NCT04035967 - Investigation of Parents' Anxiety Level and Health Related Quality of Life in Different Types of Physical Disabilities
Not yet recruiting NCT06290713 - Vasodilator and Exercise Study for DMD (VASO-REx) Phase 2